Literatur
-
1 American Heart Association .2000 Heart Statistical Update. Dallas, TX 2001
-
2
Asahara T, Murohara T, Sullivan A. et al .
Isolation of putative progenitor endothelial cells for angiogenesis.
Science.
1997;
275
964-967
-
3
Asahara T, Masuda H, Takahashi T. et al .
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.
Circ Res.
1999;
85
221-228
-
4
Askari A T, Unzek S, Popovic Z B. et al .
Effect of stromal-cell derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.
Lancet.
2003;
362
675-676
-
5
Assmus B, Schächinger V, Teupe C. et al .
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI).
Circulation.
2002;
106
3009-3017
-
6
Balsam L B, Wagers A J, Christensen J L, Kofidis T, Weissman I L, Robbins R C.
Haematopoeitic stem cells adopt mature haematopoietic fates in ischaemic myocardium.
Nature.
2004;
428
668-673
-
7
Beltrami A P, Urbanek K, Kajstura J. et al .
Evidence that human cardiac myocytes divide after myocardial infarction.
N Engl J Med.
2001;
344
1750-1757
-
8
Britten M B, Abolmaali N D, Assmus B. et al .
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
Circulation.
2003;
108
2212-2218
-
9
Chen S L, Fang W W, Ye F. et al .
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.
Am J Cardiol.
2004;
94
92-95
-
10
Fuchs S, Satler L F, Kornowski R. et al .
Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease.
J Am Coll Cardiol.
2003;
41
1721-1724
-
11
Gill M, Dias S, Hattori K. et al .
Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial progenitor cells.
Circ Res.
2001;
88
167-174
-
12
Gojo S, Gojo N, Takeda Y, Mori T. et al .
In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells.
Exp Cell Res.
2003;
288
51-59
-
13
Graf T.
Differentiation plasticity of hematopoietic cells.
Blood.
2002;
99
3089-3101
-
14
Handgretinger R, Gordon P R, Leimig T. et al .
Biology and plasticity of CD133+ hematopoietic stem cells.
Ann NY Acad Sci.
2003;
996
141-151
-
15
Heeschen C, Aicher A, Lehmann R. et al .
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.
Blood.
2003;
102
1340-1346
-
16
Heeschen C, Lehmann R, Honold J. et al .
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Circulation.
2004;
109
1615-1622
-
17
Heil M, Ziegelhoeffer T, Mees B, Schaper W.
A different outlook on the role of bone marrow stem cells in vascular growth.
Circ Res.
2004;
94
573-574
-
18
Herreros J, Prosper F, Perez A. et al .
Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.
Eur Heart J.
2003;
24
2012-2020
-
19
Jackson K A, Majka S M, Wang H. et al .
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.
J Clin Invest.
2001;
107
1395-1402
-
20
Jain M, DerSimonian H, Brenner D A. et al .
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction.
Circulation.
2001;
103
1920-1927
-
21
Kamihata H, Matsubara H, Nishiue T. et al .
Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.
Circulation.
2001;
104
1046-1052
-
22
Kang H J, Kim H S, Zhang S Y. et al .
Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
Lancet.
2004;
363
751-756
-
23
Kinnaird T, Stabile E, Burnett M S. et al .
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.
Circ Res.
2004;
94
678-685
-
24
Kocher A A, Schuster M D, Szabolcs M J. et al .
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
Nat Med.
2001;
7
430-436
-
25
Kogler G, Sensken S, Airey J A. et al .
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.
J Exp Med.
2004;
2
123-135
-
26
Körbling M, Estrov Z.
Adult stem cells for tissue repair - a new therapeutic concept?.
N Engl J Med.
2003;
349
570-582
-
27
Kuethe F, Figulla H R, Voth M. et al .
Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction.
Dtsch Med Wochenschr.
2004;
129
424-428
-
28
Kuethe F, Richartz B M, Sayer H G. et al .
Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions.
Int J Cardiol.
2004;
1
123-127
-
29
Li R K, Weisel R D, Mickle D A. et al .
Autologous porcine heart cell transplantation improved heart function after a myocardial infarction.
J Thorac Cardiovasc Surg.
2000;
119
62-68
-
30
Lin Y, Weisdorf D J, Solovey A, Hebbel R P.
Origins of circulating endothelial cells and endothelial outgrowth from blood.
J Clin Invest.
2000;
105
71-77
-
31
Lovell M J, Mathur A.
The role of stem cells for treatment of cardiovascular disease.
Cell Prolif.
2004;
37
67-87
-
32
Malouf N N, Coleman W B, Grisham J W. et al .
Adult-derived stem cells from the liver become myocytes in the heart in vivo.
Am J Pathol.
2001;
158
1929-1935
-
33
Mathur A, Martin J F.
Stem cells and repair of the heart.
Lancet.
2004;
364
183-192
-
34
Menasché P, Hagège A A, Vilquin J T. et al .
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
J Am Coll Cardiol.
2003;
41
1078-1083
-
35
Müller-Ehmsen J, Whittacker P, Kloner R A. et al .
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium.
J Mol Cell Cardiol.
2002;
34
107-116
-
36
Murry C E, Soonpaa M H, Reinecke H. et al .
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.
Nature.
2004;
428
664-668
-
37
Norol F, Merlet P, Isnard R. et al .
Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model.
Blood.
2003;
102
4361-4368
-
38
Orlic D, Kajstura J, Chimenti S. et al .
Bone marrow cells regenerate infarcted myocardium.
Nature.
2001;
410
701-705
-
39
Orlic D, Kajstura J, Chimenti S. et al .
Mobilized bone marrow cells repair the infarcted heart, improving function and survival.
Proc Natl Acad Sci USA.
2001;
98
10 344-10 349
-
40
Ohtsuka M, Takano H, Zou Y. et al .
Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization.
FASEB J.
2004;
18
851-853
-
41
Peichev M, Naiyer A J, Pereira D. et al .
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.
Blood.
2000;
95
952-958
-
42
Perin E C, Dohmann H FR, Borojevic R. et al .
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
Circulation.
2003;
107
2294-2302
-
43
Pittenger M F, Martin B J.
Mesenchymal stem cells and their potential as cardiac therapeutics.
Circ Res.
2004;
95
9-20
-
44
Rafii S, Lyden D.
Therapeutic stem and progenitor cell transplantation for organ vascularisation and regeneration.
Nat Med.
2003;
9
702-712
-
45
Rajnoch C, Chachques J C, Berrebi A, Bruneval P, Benoit M O, Carpentier A.
Cellular therapy reverses myocardial dysfunction.
J Thorac Cardiovasc Surg.
2001;
121
871-878
-
46
Reffelmann T, Dow J S, Wangde D. et al .
Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium.
J Mol Cell Cardiol.
2003;
35
607-613
-
47
Reinecke H, Poppa V, Murry C E.
Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting.
J Mol Cell Cardiol.
2002;
34
87-90
-
48
Sakai T, Li R K, Weisel R D. et al .
Fetal cell transplantation: a comparison of three cell types.
J Thorac Cardiovasc Surg.
1999;
118
715-724
-
49
Schächinger V, Assmus B, Britten M B. et al .
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final 1 year results of the TOPCARE-AMI trial.
J Am Coll Cardiol.
2004;
44
1690-9
-
50
Seiler C, Pohl T, Wustmann K. et al .
Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
Circulation.
2001;
104
2012-2017
-
51
Shintani S, Murohara T, Ikeda H. et al .
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.
Circulation.
2001;
103
2776-2779
-
52
Siminiak T, Kalawski R, Fiszer D. et al .
Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.
Am Heart J.
2004;
148
531-537
-
53
Smits P C, van Geuns R J, Poldermans D. et al .
Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.
J Am Coll Cardiol.
2003;
42
2063-2069
-
54
Stamm C, Kleine H D, Westphal B. et al .
CABG and bone marrow stem cell transplantation after myocardial infarction.
Thorac Cardiov Surg.
2004;
52
152-158
-
55
Strauer B, Brehm M, Zeus T.
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.
Circulation.
2002;
106
1913-1918
-
56
Taylor D A, Atkins B Z, Hungspreugs P. et al .
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.
Nat Med.
1998;
4
929-933
-
57
Toma C, Pittenger M F, Cahill K S, Byrne B J, Kessler P D.
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.
Circulation.
2002;
105
93-98
-
58
Tse H F, Kwong Y L, Chan J K. et al .
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.
Lancet.
2003;
361
11-12
-
59
Urbich C, Dimmeler S.
Endothelial progenitor cells. Characterization and role in vascular biology.
Circ Res.
2004;
95
343-353
-
60
Vasa M, Fichtlscherer S, Adler K. et al .
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.
Circulation.
2001;
103
2885-2890
-
61
Vulliet P R, Greely M, Halloran S M, MacDonald K A, Kittleson M D.
Intra-coronary arteriel injection of mesenchymal stromal cells and microinfarction in dogs.
Lancet.
2004;
363
783-784
-
62
Wollert K C, Meyer G P, Lotz J. et al .
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
Lancet.
2004;
364
141-148
-
63
Ziegelhoeffer T, Fernandez B, Kostin S. et al .
Bone marrow-derived cells do not incorporate into the adult growing vasculature.
Circ Res.
2004;
94
230-238
-
64
Landmesser U, Engberding N, Bahlmann F H. et al .
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Circulation .
2004;
110
1933-9
-
65
Beltrami A P, Barlucchi L, Torella D. et al .
Adult cardiac stem cells are multipotent and support myocardial regeneration.
Cell.
2004;
114
763-76
Dr. med. Gerd P. Meyer
Abteilung Kardiologie und Angiologie, Medizinische Hochschule
Carl-Neuberg-Straße 1
30625 Hannover
Phone: 0511/5323878
Fax: 0511/5323357
Email: meyer.gerdp@mh-hannover.de
